BIND Therapeutics Inc Stock Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | - | 16-07-23 |
1st Jan change | Capi. | |
---|---|---|
-1.90% | 103B | |
+1.79% | 95.28B | |
+2.82% | 22.15B | |
-16.16% | 21.02B | |
-8.35% | 18.15B | |
-41.01% | 16.73B | |
-14.89% | 16.05B | |
+4.38% | 13.68B | |
+34.21% | 12.17B |